Rigel Pharmaceuticals RIGL Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's total equity?
- Rigel Pharmaceuticals (RIGL) reported total equity of $399.9M in Q1 2026.
- How has Rigel Pharmaceuticals's total equity changed year-over-year?
- Rigel Pharmaceuticals's total equity increased by 2053.8% year-over-year, from $18.57M to $399.9M.
- What is the long-term trend for Rigel Pharmaceuticals's total equity?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's total equity has grown at a 63.0% compound annual growth rate (CAGR), from $34.03M to $391.48M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.